Teleflex Incorporated (NYSE:TFX) Shares Purchased by American Century Companies Inc.

American Century Companies Inc. lifted its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 1,277.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 136,955 shares of the medical technology company's stock after purchasing an additional 127,009 shares during the period. American Century Companies Inc. owned about 0.29% of Teleflex worth $24,376,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Janus Henderson Group PLC grew its stake in Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock worth $1,329,704,000 after acquiring an additional 147,147 shares in the last quarter. State Street Corp increased its holdings in Teleflex by 1.0% during the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company's stock worth $508,757,000 after purchasing an additional 21,291 shares during the period. Geode Capital Management LLC raised its position in Teleflex by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company's stock valued at $278,676,000 after purchasing an additional 5,746 shares in the last quarter. Cooke & Bieler LP lifted its holdings in shares of Teleflex by 22.1% in the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock worth $191,962,000 after buying an additional 195,150 shares during the period. Finally, Magnetar Financial LLC grew its position in shares of Teleflex by 105.2% during the 4th quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company's stock worth $74,990,000 after buying an additional 215,961 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.

Remove Ads

Teleflex Stock Up 0.7 %

NYSE:TFX traded up $0.94 during mid-day trading on Wednesday, hitting $141.24. 278,740 shares of the company's stock traded hands, compared to its average volume of 1,051,998. The company has a fifty day moving average of $157.48 and a 200 day moving average of $188.50. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a twelve month low of $128.55 and a twelve month high of $249.90. The company has a market capitalization of $6.55 billion, a P/E ratio of 28.08, a P/E/G ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. On average, analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.96%. The ex-dividend date was Friday, March 7th. Teleflex's payout ratio is 95.77%.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Citizens Jmp lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 27th. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Raymond James lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Piper Sandler restated a "neutral" rating and set a $140.00 target price (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. Finally, Truist Financial cut their price target on Teleflex from $200.00 to $149.00 and set a "hold" rating on the stock in a report on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.